Pharmaceuticals, Biotechnology and Life Sciences
– Process Could Significantly Reduce Cannabinoid Production Time – TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash" target="_blank"gt;#FSDDFlt;/agt;–FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA:…
Open-label, long-term extension data show durability of zilucoplan treatment effect, with sustained improvements observed in primary and secondary endpoints at…
— Q1 2019 net income of $0.64 per basic and $0.62 per diluted share and adjusted non-GAAP net income of…
— Statistically significant lower incidence of brain damage compared to control group, demonstrating neuroprotective properties of RYANODEX in treating nerve…
First Randomized Controlled Polysomnography Trial of Insomnia Medication in Alzheimer’s Disease Dementia Population Data to be Filed with FDA for…
Algiax Pharmaceuticals Appoints Dr. Ingo Lehrke and Dr. Guido Koopmans as CEO and CSO. A Proof-of-Concept Study for Neuropathic Pain…
Company to Develop Gene Editing Therapies to Permanently Reduce Risk of Coronary Artery Disease in Adults Announces Key Licensing Agreements…
DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients (API) Global Market – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. According…
DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredients (API) Global Market – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering. According…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic…